Skip to main content

Hycosan Shield

Resources

A number of resource materials are listed below that may support you in the management of patients. These may help provide information to your patient in a way that promotes compliance and understanding, whilst acknowledging that time is a common restriction for clinicians in most clinical settings.

  • Patient Resources
  • Clinic Resources
  • Ingredient Mode of actions
  • Clinical Validation
Patient Resources
Hycosan Shield Information Leaflet
Share

Hycosan Shield Information Leaflet

How to use Hycosan Shield
Share

How to use Hycosan Shield

Avoiding Eye Strain at the Office and Workplace
Share

Avoiding Eye Strain at the Office and Workplace

In this video, we will guide you through the process of setting up your home office to minimize digital eye strain. With more and more people working from home and spending long hours in front of screens, it’s essential to create a comfortable and healthy workspace. From choosing the right lighting, adjusting your computer settings, optimizing your monitor position, and incorporating regular breaks, we’ll cover all the necessary steps to protect your eyes and improve productivity. Whether you’re a remote worker, a student studying from home, or someone who simply spends a lot of time on digital devices, this video is for you. Say goodbye to tired and strained eyes and say hello to an efficient and enjoyable work environment.

Dry Eye Disease Paediatric Leaflet
Share

Dry Eye Disease Paediatric Leaflet

MGD Patient Booklet
Share
Dry Eye Disease Patient Booklet
Share

Dry Eye Disease Patient Booklet

Dry Eye Disease in Diabetes Patients
Share

Dry Eye Disease in Diabetes Patients

Blepharitis Patient Booklet
Share

Blepharitis Patient Booklet

The patient information booklet on blepharitis offers comprehensive insights into this common eyelid condition, covering symptoms, causes, and evidence-based treatment strategies. Designed for medical professionals and patients alike, it provides clear guidance on managing inflammation, promoting eyelid hygiene, and recommending appropriate therapies such as warm compresses and eyelid cleansing techniques. This resource equips healthcare providers with essential information to educate patients effectively, fostering proactive management and improved outcomes for individuals dealing with blepharitis.

Clinic Resources
OSDI Questionnaire

OSDI Questionnaire

Iatrogenic Medication Checklist

Iatrogenic Medication Checklist

Iatrogenic Dry Eye Checklist

Iatrogenic Dry Eye Checklist

Anatomy Of The Eye Cornea Tear Film Poster
Share

Anatomy Of The Eye Cornea Tear Film Poster

DEQ-5 Patient Dry Eye Questionnaire
Share

DEQ-5 Patient Dry Eye Questionnaire

This Questionnaire is designed to be used in clinic when consulting a patient to help diagnose and manage their dry eye disease.

Ingredient Mode of actions
Semifluorinated Alkanes in the Treatment of MGD - 2017

Semifluorinated Alkanes in the Treatment of MGD - 2017

Summary of Clinical Studies

Summary of Clinical Studies

Semifluorinated Alkane Drops for Treatment of Dry Eye Disease

Semifluorinated Alkane Drops for Treatment of Dry Eye Disease

Clinical Validation
Semifluorinated Alkane Eye Drops in Chronic Ocular Graft-versus-Host Disease: A Prospective, Multicenter, Noninterventional Study

Semifluorinated Alkane Eye Drops in Chronic Ocular Graft-versus-Host Disease: A Prospective, Multicenter, Noninterventional Study

Long-Term Safety and Efficacy of Perfluorohexyloctane Ophthalmic Solution for the Treatment of Patients With Dry Eye Disease: The KALAHARI Study

Long-Term Safety and Efficacy of Perfluorohexyloctane Ophthalmic Solution for the Treatment of Patients With Dry Eye Disease: The KALAHARI Study

Efficacy of NOV03 (Perfluorohexyloctane) on Signs and Symptoms of Dry Eye Disease associated with Meibomian Gland Dysfunction: The Mojave study

Efficacy of NOV03 (Perfluorohexyloctane) on Signs and Symptoms of Dry Eye Disease associated with Meibomian Gland Dysfunction: The Mojave study

NOV03 for Dry Eye Disease Associated with Meibomian Gland Dysfunction: Results of the Randomized Phase 3 GOBI Study

NOV03 for Dry Eye Disease Associated with Meibomian Gland Dysfunction: Results of the Randomized Phase 3 GOBI Study

A Randomized Clinical Study (SEECASE) to Assess Efficacy, Safety, and Tolerability of NOV03 for Treatment of Dry Eye Disease

A Randomized Clinical Study (SEECASE) to Assess Efficacy, Safety, and Tolerability of NOV03 for Treatment of Dry Eye Disease

Comparison of the Clinical Efficacy of Three Different Eye Drops for the Treatment of Dry Eye

Comparison of the Clinical Efficacy of Three Different Eye Drops for the Treatment of Dry Eye

Semi-fluorinated Alkane Eye Drops Reduce Signs and Symptoms of Evaporative Dry Eye Disease After Cataract Surgery

Semi-fluorinated Alkane Eye Drops Reduce Signs and Symptoms of Evaporative Dry Eye Disease After Cataract Surgery

Evaluating the lubricating effect of semifluorinated alkanes on the ocular surface

Evaluating the lubricating effect of semifluorinated alkanes on the ocular surface

Effects and safety of perfluorohexyloctane on the eye surface and corneal endothelium

Effects and safety of perfluorohexyloctane on the eye surface and corneal endothelium

Preclinical studies evaluating the effect of semifluorinated alkanes on ocular surface and tear fluid dynamics

Preclinical studies evaluating the effect of semifluorinated alkanes on ocular surface and tear fluid dynamics

Semifluorinated Alkane Eye Drops for Treatment of Dry Eye Disease—A Prospective, Multicenter Noninterventional Study

Semifluorinated Alkane Eye Drops for Treatment of Dry Eye Disease—A Prospective, Multicenter Noninterventional Study

Semifluorinated alkane eye drops for treat-ment of dry eye disease due to meibomiangland disease

Semifluorinated alkane eye drops for treat-ment of dry eye disease due to meibomiangland disease

Influence of perfluorohexyloctane eyedrops on tear film thickness in patientswith mild to moderate dry eye disease: arandomized controlled clinical trial

Influence of perfluorohexyloctane eyedrops on tear film thickness in patientswith mild to moderate dry eye disease: arandomized controlled clinical trial

Related Articles

Scope updates
Glaucoma in People of Black Ethnic Background
Apr 3, 2025
Ian Rodrigues, MBBS, BSc (Hons), FRCS (Glasg), FRCOphth, PgCert, FEBOS
Scope updates
The Role of Ophthalmic Ointments in Night-Time Exposure and RCE: A Roundtable Discussion
Jan 16, 2025
Paul Karpecki, OD, FAAO, Cory Lappin, OD, MS, FAAO, Ada Noh, OD
Scope updates
Orbito-Zygomatic Ostepblastoma: Unusual Lesion, Unusual Location
Dec 6, 2024
Miss Bhavna Sharma, Senior Oculoplastics Fellow
Scope updates
Bilateral pigment dispersion glaucoma
Sep 16, 2024
John Davidson

Are you a healthcare or eye care professional?

The information contained on this website is provided exclusively for healthcare and eye care professionals and is not intended for patients.

Click ‘Yes’ below to confirm that you are a healthcare professional and agree to the terms of use.

If you select ‘No’, you will be redirected to scopeeyecare.com

Yes No

This will close in 0 seconds